Author

S. Dowall

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2 Pathology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Organism:mouse· 3 Research Focus:drug response / drug discovery· 2 Research Focus:host-pathogen & immune response· 2 Organism:non-human primate· 1

Frequent Co-Authors

E. Rayner· 2 shared S. Findlay-Wilson· 2 shared A. Flaxman· 1 shared A. Mirazimi· 1 shared A. Reyes-Sandoval· 1 shared A. Spencer· 1 shared B. E. Cavell· 1 shared B. Y. Chua· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

E. Rayner

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Zaire ebolavirus, Sudan ebolavirus, Marburg and Lassa viruses

A. Flaxman, S. Sebastian, S. Appelberg, K. Cha, M. Ulaszewska, J. Purushotham, C. Gilbride, H. Sharpe, A. Spencer, S. Bibi, D. Wright, S. Dowall, L. Easterbrook, S. Findlay-Wilson, S. Gilbert, , T. Lambe

This paper develops a multi-pathogen vaccine targeting Zaire ebolavirus, Sudan ebolavirus, Marburg and Lassa viruses, showing strong immunogenicity and protective efficacy in animal models.

bioRxiv · Nov 3, 2023 · PreprintImmunology

Prophylactic intranasal administration of a TLR2 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model

P. C. Proud, D. Tsitoura, R. J. Watson, B. Y. Chua, M. J. Aram, K. R. Bewley, B. E. Cavell, R. Cobb, S. Dowall, S. A. Fotheringham, C. M. Ho, V. Lucas, D. Ngabo, E. Rayner, K. A. Ryan, , M. W. Carroll

bioRxiv · Sep 25, 2020Immunology

A Zika vaccine based on chimpanzee adenovirus ChAdOx1 elicits lineage-transcending sterile immunity and prevents colonisation of brain and ovaries

C. Lopez-Camacho, S. Dowall, V. Graham, S. Findlay-Wilson, E. Rayner, Y. Chan Kim, R. Hewson, A. Reyes-Sandoval

This paper evaluates a ZIKV vaccine based on chimpanzee adenovirus ChAdOx1, showing it provides sterile immunity against both Asian and African lineages and prevents viral colonization of brain and ovaries.

bioRxiv · Jan 14, 2019 · PreprintPathology